Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Adler

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
PDA Journal of Pharmaceutical Science and Technology|January 23, 2016
The Pharmaceutical Capping Process-Correlation between Residual Seal Force, Torque Moment, and Flip-off Removal ForceRoman Mathaes, Hanns-Christian Mahler, Lothar Vorgrimler, et al.
Journal of Hepatology|December 15, 2010
Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver diseaseEric Trépo, Andrej Potthoff, Pierre Pradat, et al.
NPJ Vaccines|May 22, 2020
New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routesMario Amacker, Charli Smardon, Laura Mason, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 28, 2006
Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusionVincent Donckier, Roberto Troisi, Alain Le Moine, et al.
The New England Journal of Medicine|September 16, 2011
Response-guided telaprevir combination treatment for hepatitis C virus infectionKenneth E Sherman, Steven L Flamm, Nezam H Afdhal, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial managementBénédicte De Vroey, Christophe Moreno, Wim Laleman, et al.
Acta Gastro-Enterologica Belgica|May 10, 2012
HBV infection in Belgium: results of the BASL observatory of 1,456 HBsAg carriersPierre Deltenre, Wim Laleman, Marc Van Gossum, et al.
Toxicon : Official Journal of the International Society on Toxinology|July 13, 2017
Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype AAlan R Jacobson, Michael Adler, Nicholas R Silvaggi, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
PDA Journal of Pharmaceutical Science and Technology|January 23, 2016
The Pharmaceutical Capping Process-Correlation between Residual Seal Force, Torque Moment, and Flip-off Removal ForceRoman Mathaes, Hanns-Christian Mahler, Lothar Vorgrimler, et al.
Journal of Hepatology|December 15, 2010
Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver diseaseEric Trépo, Andrej Potthoff, Pierre Pradat, et al.
NPJ Vaccines|May 22, 2020
New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routesMario Amacker, Charli Smardon, Laura Mason, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 28, 2006
Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusionVincent Donckier, Roberto Troisi, Alain Le Moine, et al.
The New England Journal of Medicine|September 16, 2011
Response-guided telaprevir combination treatment for hepatitis C virus infectionKenneth E Sherman, Steven L Flamm, Nezam H Afdhal, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial managementBénédicte De Vroey, Christophe Moreno, Wim Laleman, et al.
Acta Gastro-Enterologica Belgica|May 10, 2012
HBV infection in Belgium: results of the BASL observatory of 1,456 HBsAg carriersPierre Deltenre, Wim Laleman, Marc Van Gossum, et al.
Toxicon : Official Journal of the International Society on Toxinology|July 13, 2017
Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype AAlan R Jacobson, Michael Adler, Nicholas R Silvaggi, et al.
Pageof 11